Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Protalix BioTherapeutics, Inc. (PLX)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
3 Jan 2023
Schwartz Aharon
Director
Protalix BioTherapeutics, Inc.
(PLX)
174,000
+171%
110,000
$1.42
$155,815.00
BUY
11 Apr 2022
Bashan Dror
President and CEO, Director, Officer
Protalix BioTherapeutics, Inc.
(PLX)
68,000
+100%
68,000
$1.50
$102,000.00
SELL
2 Jun 2021
Dexcel Pharma Technologies Ltd.
10% Owner
Protalix BioTherapeutics, Inc.
(PLX)
3,637,314
-20%
918,717
$2.27
$2,088,857.40
BUY
7 Apr 2020
Schwartz Aharon
Director
Protalix BioTherapeutics, Inc.
(PLX)
64,000
+100%
64,000
$2.43
$155,264.00
BUY
16 May 2017
Manor Moshe
President & CEO, Director, Officer
Protalix BioTherapeutics, Inc.
(PLX)
50,000
+11%
5,000
$8.10
$40,500.00
SELL
2 Dec 2016
Camber Capital Management LLC
10% Owner
Protalix BioTherapeutics, Inc.
(PLX)
10,775,000
-2%
250,000
$3.17
$792,000.00
Home